Publications

Found 131 results
Filters: Keyword is Mice  [Clear All Filters]
2012
Salmon, D., G. Vanwalleghem, Y. Morias, J. Denoeud, C. Krumbholz, F. Lhommé, S. Bachmaier, M. Kador, J. Gossmann, F. Braga Steh Dias, et al., "Adenylate cyclases of Trypanosoma brucei inhibit the innate immune response of the host.", Science, vol. 337, issue 6093, pp. 463-6, 2012 Jul 27.
Caljon, G., B. Stijlemans, D. Saerens, J. Van Den Abbeele, S. Muyldermans, S. Magez, and P. De Baetselier, "Affinity is an important determinant of the anti-trypanosome activity of nanobodies.", PLoS Negl Trop Dis, vol. 6, issue 11, pp. e1902, 2012.
Tiels, P., E. Baranova, K. Piens, C. De Visscher, G. Pynaert, W. Nerinckx, J. Stout, F. Fudalej, P. Hulpiau, S. Tännler, et al., "A bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes.", Nat Biotechnol, vol. 30, issue 12, pp. 1225-31, 2012 Dec.
D'huyvetter, M., A. Aerts, C. Xavier, I. Vaneycken, N. Devoogdt, M. Gijs, N. Impens, S. Baatout, B. Ponsard, S. Muyldermans, et al., "Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.", Contrast Media Mol Imaging, vol. 7, issue 2, pp. 254-64, 2012 Mar-Apr.
Zhu, J., J. Declercq, B. Roucourt, G. H. Ghassabeh, S. Meulemans, J. Kinne, G. David, A. J. M. Vermorken, W. J. M. Van de Ven, I. Lindberg, et al., "Generation and characterization of non-competitive furin-inhibiting nanobodies.", Biochem J, vol. 448, issue 1, pp. 73-82, 2012 Nov 15.
Copin, R., M-A. Vitry, D. Hanot Mambres, A. Machelart, C. De Trez, J-M. Vanderwinden, S. Magez, S. Akira, B. Ryffel, Y. Carlier, et al., "In situ microscopy analysis reveals local innate immune response developed around Brucella infected cells in resistant and susceptible mice.", PLoS Pathog, vol. 8, issue 3, pp. e1002575, 2012.
Hegyi, H., and P. Tompa, "Increased structural disorder of proteins encoded on human sex chromosomes.", Mol Biosyst, vol. 8, issue 1, pp. 229-36, 2012 Jan.
Broisat, A., S. Hernot, J. Toczek, J. De Vos, L. M. Riou, S. Martin, M. Ahmadi, N. Thielens, U. Wernery, V. Caveliers, et al., "Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions.", Circ Res, vol. 110, issue 7, pp. 927-37, 2012 Mar 30.
Hernot, S., S. Unnikrishnan, Z. Du, T. Shevchenko, B. Cosyns, A. Broisat, J. Toczek, V. Caveliers, S. Muyldermans, T. Lahoutte, et al., "Nanobody-coupled microbubbles as novel molecular tracer.", J Control Release, vol. 158, issue 2, pp. 346-53, 2012 Mar 10.
Tantos, Á., and P. Tompa, "Proteomic methods for the identification of intrinsically disordered proteins.", Methods Mol Biol, vol. 896, pp. 429-37, 2012.
2011
Roovers, R. C., M. J. W. D. Vosjan, T. Laeremans, R. el Khoulati, R. C. G. de Bruin, K. M. Ferguson, A. J. Verkleij, G. A. M. S. van Dongen, and P. M. P. van Be Henegouwen, "A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth.", Int J Cancer, vol. 129, issue 8, pp. 2013-24, 2011 Oct 15.
Abskharon, R. N. N., S. H. Soror, E. Pardon, H. El Hassan, G. Legname, J. Steyaert, and A. Wohlkonig, "Combining in-situ proteolysis and microseed matrix screening to promote crystallization of PrPc-nanobody complexes.", Protein Eng Des Sel, vol. 24, issue 9, pp. 737-41, 2011 Sep.
Gainkam, L. Olive Tcho, M. Keyaerts, V. Caveliers, N. Devoogdt, C. Vanhove, L. Van Grunsven, S. Muyldermans, and T. Lahoutte, "Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy.", Mol Imaging Biol, vol. 13, issue 5, pp. 940-8, 2011 Oct.
Turinsky, A. L., B. Turner, R. C. Borja, J. A. Gleeson, M. Heath, S. Pu, T. Switzer, D. Dong, Y. Gong, T. On, et al., "DAnCER: disease-annotated chromatin epigenetics resource.", Nucleic Acids Res, vol. 39, issue Database issue, pp. D889-94, 2011 Jan.
Ben Abderrazek, R., C. Vincke, I. Hmila, D. Saerens, N. Abidi, M. El Ayeb, S. Muyldermans, and B. Bouhaouala-Zahar, "Development of Cys38 knock-out and humanized version of NbAahII10 nanobody with improved neutralization of AahII scorpion toxin.", Protein Eng Des Sel, vol. 24, issue 9, pp. 727-35, 2011 Sep.
Stijlemans, B., G. Caljon, S. Kumar A. Natesan, D. Saerens, K. Conrath, D. Pérez-Morga, J. N. Skepper, A. Nikolaou, L. Brys, E. Pays, et al., "High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis.", PLoS Pathog, vol. 7, issue 6, pp. e1002072, 2011 Jun.
Geurts, N., E. Martens, S. Verhenne, N. Lays, G. Thijs, S. Magez, B. Cauwe, S. Li, H. Heremans, G. Opdenakker, et al., "Insufficiently defined genetic background confounds phenotypes in transgenic studies as exemplified by malaria infection in Tlr9 knockout mice.", PLoS One, vol. 6, issue 11, pp. e27131, 2011.

Pages